Antiviral Drug News and Research

RSS
Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Important structures of SARS-CoV-2 PLpro protease

Important structures of SARS-CoV-2 PLpro protease

First antiviral treatment for COVID-19 receives FDA approval

First antiviral treatment for COVID-19 receives FDA approval

SARS-CoV-2 hijacks mitochondria

SARS-CoV-2 hijacks mitochondria

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain could guide design of antiviral agents

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain could guide design of antiviral agents

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Scientists discover a novel antiviral strategy for treating COVID-19

Scientists discover a novel antiviral strategy for treating COVID-19

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Study confirms SARS-CoV-2 spike glycoprotein promotes a hyper-inflammatory immune response

Study confirms SARS-CoV-2 spike glycoprotein promotes a hyper-inflammatory immune response

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

New book gives overview of viruses and how they emerge to cause pandemics

New book gives overview of viruses and how they emerge to cause pandemics

Study highlights need to understand different environmental conditions that affect surface chemistry of SARS-CoV-2

Study highlights need to understand different environmental conditions that affect surface chemistry of SARS-CoV-2

Additional $400,000 awarded for research projects focused on cardiovascular impact of COVID-19

Additional $400,000 awarded for research projects focused on cardiovascular impact of COVID-19

DHODH inhibitor PTC299 shows potential as a COVID-19 therapeutic

DHODH inhibitor PTC299 shows potential as a COVID-19 therapeutic

Keck Medicine of USC participates in clinical trial to evaluate antiviral drug as possible COVID-19 treatment

Keck Medicine of USC participates in clinical trial to evaluate antiviral drug as possible COVID-19 treatment

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Innovative clinical trial platform launched to accelerate testing of COVID-19 drugs

Innovative clinical trial platform launched to accelerate testing of COVID-19 drugs

Scientists identify compounds that block replication of COVID-19 virus

Scientists identify compounds that block replication of COVID-19 virus

New platform prioritizes synergistic drug combinations against SARS-CoV-2

New platform prioritizes synergistic drug combinations against SARS-CoV-2